Endoscopic Treatment of Bronchial Carcinoid Tumors

Status Completed

Clinical Trial Summary

Carcinoid tumors of the lung are considered to be a low-grade malignancy. Surgical resection is considered the standard approach. Recent data has shown that a complete endoscopic treatment could be considered. An endoscopic treatment is can be a alternative to invasive surgery.

Clinical Trial Description

The objective of this study is to evaluate the feasibility and therapeutic method of endoscopic treatment of bronchial carcinoid tumors. ;

Study Design

Related Conditions & MeSH terms

Carcinoid Tumor

Clinical Trial Details

NCT number	NCT03723499
Study type	Observational
Source	Centre Hospitalier Universitaire de Saint Etienne
Contact
Status	Completed
Phase
Start date	November 1995
Completion date	December 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05636618` - Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors	Phase 1/Phase 2
Recruiting	`NCT04993261` - An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors	Early Phase 1
Recruiting	`NCT04907643` - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	N/A
Active, not recruiting	`NCT03375320` - Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors	Phase 3
Completed	`NCT01435122` - A Study of Axitinib in Advanced Carcinoid Tumors	Phase 2
Not yet recruiting	`NCT04039516` - Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy	Phase 2
Completed	`NCT00780663` - Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma	Phase 2
Completed	`NCT00804336` - Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors	Phase 1
Recruiting	`NCT04017104` - Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
Recruiting	`NCT04028479` - The Registry of Oncology Outcomes Associated With Testing and Treatment
Completed	`NCT00328497` - A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors	Phase 2
Completed	`NCT02399215` - Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors	Phase 2
Terminated	`NCT03420521` - Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors	Phase 2
Active, not recruiting	`NCT05477576` - Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy	Phase 3
Not yet recruiting	`NCT02038738` - 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors	Phase 1/Phase 2
Completed	`NCT01024387` - AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors	Phase 2
Completed	`NCT00446082` - Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease	Phase 1
Active, not recruiting	`NCT05361668` - Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome	Phase 2
Completed	`NCT01466036` - Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors	Phase 2
Completed	`NCT01398306` - Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.